(Mark One)
|
|||
|
Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
for the Quarterly Period Ended March 31, 2017
|
||
or
|
|||
|
Transition Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
for the transition period from ____ to ____
|
Commission File Number 001-14785
|
GSE Systems, Inc.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
52-1868008
|
|
(State of incorporation)
|
(I.R.S. Employer Identification Number)
|
|
1332 Londontown Blvd., Suite 200, Sykesville MD
|
21784
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (410) 970-7800
|
Large accelerated filer
|
Accelerated filer
|
Non-accelerated filer
|
Smaller reporting company
|
(Do not check if a smaller reporting company)
|
PAGE
|
|||
PART I.
|
FINANCIAL INFORMATION
|
3
|
|
Item 1.
|
Financial Statements:
|
||
Consolidated Balance Sheets as of March 31, 2017 (unaudited) and December 31, 2016
|
3
|
||
Unaudited Consolidated Statements of Operations for the Three Months Ended March 31, 2017 and March 31, 2016
|
4
|
||
Unaudited Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended March 31, 2017 and March 31, 2016
|
5
|
||
Unaudited Consolidated Statement of Changes in Stockholders' Equity for the Three Months Ended March 31, 2017
|
6
|
||
Unaudited Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2017 and March 31, 2016
|
7
|
||
Notes to Consolidated Financial Statements
|
8
|
||
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
21
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
37
|
|
Item 4.
|
Controls and Procedures
|
37
|
|
PART II.
|
OTHER INFORMATION
|
38
|
|
Item 1.
|
Legal Proceedings
|
38
|
|
Item 1A.
|
Risk Factors
|
38
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
38
|
|
Item 3.
|
Defaults Upon Senior Securities
|
38
|
|
Item 4.
|
Mine Safety Disclosures
|
38
|
|
Item 5.
|
Other Information
|
38
|
|
Item 6.
|
Exhibits
|
38
|
|
SIGNATURES
|
39
|
Item 1. |
Financial Statements
|
March 31, 2017
|
December 31, 2016
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
21,625
|
$
|
21,747
|
||||
Restricted cash
|
1,140
|
1,140
|
||||||
Contract receivables, net
|
13,897
|
18,863
|
||||||
Prepaid expenses and other current assets
|
4,024
|
2,052
|
||||||
Total current assets
|
40,686
|
43,802
|
||||||
Equipment, software, and leasehold improvements
|
6,845
|
6,759
|
||||||
Accumulated depreciation
|
(5,648
|
)
|
(5,527
|
)
|
||||
Equipment, software, and leasehold improvements, net
|
1,197
|
1,232
|
||||||
Software development costs, net
|
894
|
982
|
||||||
Goodwill
|
5,612
|
5,612
|
||||||
Intangible assets, net
|
402
|
454
|
||||||
Other assets
|
72
|
1,574
|
||||||
Total assets
|
$
|
48,863
|
$
|
53,656
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
587
|
$
|
923
|
||||
Accrued expenses
|
2,389
|
2,437
|
||||||
Accrued compensation
|
2,015
|
2,624
|
||||||
Billings in excess of revenue earned
|
18,192
|
21,444
|
||||||
Accrued warranty
|
1,209
|
1,137
|
||||||
Contingent consideration
|
1,508
|
2,105
|
||||||
Other current liabilities
|
750
|
716
|
||||||
Total current liabilities
|
26,650
|
31,386
|
||||||
Other liabilities
|
1,261
|
1,149
|
||||||
Total liabilities
|
27,911
|
32,535
|
||||||
Commitments and contingencies
|
||||||||
Stockholders' equity:
|
||||||||
Preferred stock $0.01 par value, 2,000,000 shares authorized, no shares issued and outstanding
|
-
|
-
|
||||||
Common stock $0.01 par value, 30,000,000 shares authorized, 20,777,168 and 20,433,608 shares issued and 19,178,257 and 18,834,697 shares outstanding
|
208
|
204
|
||||||
Additional paid-in capital
|
75,120
|
75,120
|
||||||
Accumulated deficit
|
(49,693
|
)
|
(49,427
|
)
|
||||
Accumulated other comprehensive loss
|
(1,684
|
)
|
(1,777
|
)
|
||||
Treasury stock at cost, 1,598,911 shares in 2017 and 2016
|
(2,999
|
)
|
(2,999
|
)
|
||||
Total stockholders' equity
|
20,952
|
21,121
|
||||||
Total liabilities and stockholders' equity
|
$
|
48,863
|
$
|
53,656
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Revenue
|
$
|
16,342
|
$
|
12,976
|
||||
Cost of revenue
|
12,220
|
9,352
|
||||||
Gross profit
|
4,122
|
3,624
|
||||||
Operating expenses:
|
||||||||
Selling, general and administrative
|
3,592
|
2,757
|
||||||
Research and development
|
402
|
354
|
||||||
Restructuring charges
|
45
|
125
|
||||||
Depreciation
|
76
|
100
|
||||||
Amortization of definite-lived intangible assets
|
64
|
73
|
||||||
Total operating expenses
|
4,179
|
3,409
|
||||||
Operating (loss) income
|
(57
|
)
|
215
|
|||||
Interest income, net
|
27
|
27
|
||||||
Loss on derivative instruments, net
|
(160
|
)
|
(118
|
)
|
||||
Other (expense) income, net
|
(3
|
)
|
102
|
|||||
(Loss) income before income taxes
|
(193
|
)
|
226
|
|||||
Provision for income taxes
|
73
|
88
|
||||||
Net (loss) income
|
$
|
(266
|
)
|
$
|
138
|
|||
Basic (loss) earnings per common share
|
$
|
(0.01
|
)
|
$
|
0.01
|
|||
Diluted (loss) earnings per common share
|
$
|
(0.01
|
)
|
$
|
0.01
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Net (loss) income
|
$
|
(266
|
)
|
$
|
138
|
|||
Foreign currency translation adjustment
|
93
|
49
|
||||||
Comprehensive (loss) income
|
$
|
(173
|
)
|
$
|
187
|
Common
Stock
|
Treasury
Stock
|
|||||||||||||||||||||||||||||||
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive
Loss
|
Shares
|
Amount
|
Total
|
|||||||||||||||||||||||||
Balance, January 1, 2017
|
20,434
|
$
|
204
|
$
|
75,120
|
$
|
(49,427
|
)
|
$
|
(1,777
|
)
|
(1,599
|
)
|
$
|
(2,999
|
)
|
$
|
21,121
|
||||||||||||||
Stock-based compensation expense
|
-
|
-
|
614
|
-
|
-
|
-
|
-
|
614
|
||||||||||||||||||||||||
Common stock issued for options exercised
|
31
|
1
|
61
|
-
|
-
|
-
|
-
|
62
|
||||||||||||||||||||||||
Common stock issued for RSUs vested
|
312
|
3
|
(3
|
)
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||
Vested RSU shares withheld to pay taxes
|
-
|
-
|
(672
|
)
|
-
|
-
|
-
|
-
|
(672
|
)
|
||||||||||||||||||||||
Foreign currency translation adjustment
|
-
|
-
|
-
|
-
|
93
|
-
|
-
|
93
|
||||||||||||||||||||||||
Net loss
|
-
|
-
|
-
|
(266
|
)
|
-
|
-
|
-
|
(266
|
)
|
||||||||||||||||||||||
Balance, March 31, 2017
|
20,777
|
$
|
208
|
$
|
75,120
|
$
|
(49,693
|
)
|
$
|
(1,684
|
)
|
(1,599
|
)
|
$
|
(2,999
|
)
|
$
|
20,952
|
Three months ended
March 31,
|
||||||||
2017
|
2016
|
|||||||
Cash flows from operating activities:
|
||||||||
Net (loss) income
|
$
|
(266
|
)
|
$
|
138
|
|||
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
|
||||||||
Depreciation
|
76
|
100
|
||||||
Amortization of definite-lived intangible assets
|
64
|
73
|
||||||
Amortization of capitalized software development costs
|
117
|
81
|
||||||
Change in fair value of contingent consideration
|
254
|
(69
|
)
|
|||||
Stock-based compensation expense
|
596
|
247
|
||||||
Loss on derivative instruments, net
|
160
|
118
|
||||||
Deferred income taxes
|
-
|
36
|
||||||
Gain on sale of equipment, software, and leasehold improvements
|
-
|
(1
|
)
|
|||||
Changes in assets and liabilities:
|
||||||||
Contract receivables, net
|
4,937
|
334
|
||||||
Prepaid expenses and other assets
|
(523
|
)
|
(515
|
)
|
||||
Accounts payable, accrued compensation, and accrued expenses
|
(1,184
|
)
|
1,226
|
|||||
Billings in excess of revenue earned
|
(3,279
|
)
|
(492
|
)
|
||||
Accrued warranty
|
67
|
(101
|
)
|
|||||
Other liabilities
|
325
|
465
|
||||||
Cash provided by operating activities
|
1,344
|
1,640
|
||||||
Cash flows from investing activities:
|
||||||||
Proceeds from sale of equipment, software and leasehold improvement
|
-
|
31
|
||||||
Capital expenditures
|
(44
|
)
|
(18
|
)
|
||||
Capitalized software development costs
|
(29
|
)
|
(131
|
)
|
||||
Restrictions of cash as collateral under letters of credit
|
-
|
(2
|
)
|
|||||
Releases of cash as collateral under letters of credit
|
-
|
1
|
||||||
Cash used in investing activities
|
(73
|
)
|
(119
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Proceeds from issuance of common stock on the exercise of stock options
|
62
|
4
|
||||||
Contingent consideration payments to Hyperspring, LLC
|
(851
|
)
|
(1,421
|
)
|
||||
RSUs withheld to pay taxes
|
(672
|
)
|
-
|
|||||
Cash used in financing activities
|
(1,461
|
)
|
(1,417
|
)
|
||||
Effect of exchange rate changes on cash
|
68
|
37
|
||||||
Net (decrease) increase in cash and cash equivalents
|
(122
|
)
|
141
|
|||||
Cash and cash equivalents at beginning of year
|
21,747
|
11,084
|
||||||
Cash and cash equivalents at end of period
|
$
|
21,625
|
$
|
11,225
|
1. |
Summary of Significant Accounting Policies
|
● |
Performance Improvement Solutions (approximately 59% of revenue)
|
● |
Nuclear Industry Training and Consulting (approximately 41% of revenue)
|
2. |
Recent Accounting Pronouncements
|
3. |
Basic and Diluted Earnings (Loss) per Common Share
|
(in thousands, except for share amounts)
|
Three months ended
|
|||||||
March 31,
|
||||||||
2017
|
2016
|
|||||||
Numerator:
|
||||||||
Net (loss) income
|
$
|
(266
|
)
|
$
|
138
|
|||
Denominator:
|
||||||||
Weighted-average shares outstanding for basic (loss) income per share
|
19,094,382
|
17,912,045
|
||||||
Effect of dilutive securities:
|
||||||||
Stock options and restricted stock units
|
-
|
221,697
|
||||||
Adjusted weighted-average shares outstanding and assumed conversions for diluted (loss) income per share
|
19,094,382
|
18,133,742
|
||||||
Shares related to dilutive securities excluded because inclusion would be anti-dilutive
|
564,833
|
752,042
|
4. |
Contingent Consideration
|
5. |
Contract Receivables
|
(in thousands)
|
March 31,
|
December 31,
|
||||||
2017
|
2016
|
|||||||
Billed receivables
|
$
|
5,971
|
$
|
13,325
|
||||
Recoverable costs and accrued profit not yet billed
|
7,944
|
5,555
|
||||||
Allowance for doubtful accounts
|
(18
|
)
|
(17
|
)
|
||||
Total contract receivables, net
|
$
|
13,897
|
$
|
18,863
|
6. |
Prepaid Expenses and Other Current Assets
|
(in thousands)
|
March 31,
|
December 31,
|
||||||
2017
|
2016
|
|||||||
Inventory
|
$
|
2,158
|
$
|
-
|
||||
Income taxes receivable
|
380
|
446
|
||||||
Prepaid expenses
|
583
|
422
|
||||||
Other current assets
|
903
|
1,184
|
||||||
Total prepaid expenses and other current assets
|
$
|
4,024
|
$
|
2,052
|
7. |
Software Development Costs, Net
|
8. |
Goodwill and Intangible Assets
|
9. |
Fair Value of Financial Instruments
|
(in thousands)
|
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
Money market funds
|
$
|
12,145
|
$
|
-
|
$
|
-
|
$
|
12,145
|
||||||||
Foreign exchange contracts
|
-
|
71
|
-
|
71
|
||||||||||||
Total assets
|
$
|
12,145
|
$
|
71
|
$
|
-
|
$
|
12,216
|
||||||||
Foreign exchange contracts
|
$
|
-
|
$
|
(36
|
)
|
$
|
-
|
$
|
(36
|
)
|
||||||
Contingent consideration
|
-
|
-
|
(1,508
|
)
|
(1,508
|
)
|
||||||||||
Total liabilities
|
$
|
-
|
$
|
(36
|
)
|
$
|
(1,508
|
)
|
$
|
(1,544
|
)
|
(in thousands)
|
Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
Money market funds
|
$
|
16,435
|
$
|
-
|
$
|
-
|
$
|
16,435
|
||||||||
Foreign exchange contracts
|
-
|
141
|
-
|
141
|
||||||||||||
Total assets
|
$
|
16,435
|
$
|
141
|
$
|
-
|
$
|
16,576
|
||||||||
Foreign exchange contracts
|
$
|
-
|
$
|
(20
|
)
|
$
|
-
|
$
|
(20
|
)
|
||||||
Contingent consideration
|
-
|
-
|
(2,105
|
)
|
(2,105
|
)
|
||||||||||
Total liabilities
|
$
|
-
|
$
|
(20
|
)
|
$
|
(2,105
|
)
|
$
|
(2,125
|
)
|
|||||
(in thousands)
|
||||
Balance, January 1, 2017
|
$
|
2,105
|
||
Payments made on contingent liabilities
|
(851
|
)
|
||
Change in fair value
|
254
|
|||
Balance, March 31, 2017
|
$
|
1,508
|
10. |
Derivative Instruments
|
March 31,
|
December 31,
|
|||||||
(in thousands)
|
2017
|
2016
|
||||||
Asset derivatives
|
||||||||
Prepaid expenses and other current assets
|
$
|
27
|
$
|
57
|
||||
Other assets
|
44
|
84
|
||||||
71
|
141
|
|||||||
Liability derivatives
|
||||||||
Other current liabilities
|
(36
|
)
|
(20
|
)
|
||||
(36
|
)
|
(20
|
)
|
|||||
Net fair value
|
$
|
35
|
$
|
121
|
Three months ended
March 31,
|
||||||||
(in thousands)
|
2017
|
2016
|
||||||
Foreign exchange contracts - change in fair value
|
$
|
(86
|
)
|
$
|
(183
|
)
|
||
Remeasurement of related contract receivables,
and billings in excess of revenue earned
|
(74
|
)
|
65
|
|||||
Loss on derivative instruments, net
|
$
|
(160
|
)
|
$
|
(118
|
)
|
11. |
Stock-Based Compensation
|
12. |
Debt
|
13. |
Product Warranty
|
(in thousands)
|
||||
Balance, January 1, 2017
|
$
|
1,478
|
||
Current period provision
|
235
|
|||
Current period claims
|
(62
|
)
|
||
Currency adjustment
|
2
|
|||
Balance, March 31, 2017
|
$
|
1,653
|
14. |
Income Taxes
|
Three months ended
March 31,
|
||||||||
($ in thousands)
|
2017
|
2016
|
||||||
Provision for income taxes
|
$
|
73
|
$
|
88
|
||||
Effective tax rate
|
(37.8
|
%)
|
38.6
|
%
|
15. |
Segment Information
|
(in thousands)
|
Three months ended
|
|||||||
March 31,
|
||||||||
2017
|
2016
|
|||||||
Revenue:
|
||||||||
Performance Improvement Solutions
|
$
|
9,670
|
$
|
8,843
|
||||
Nuclear Industry Training and Consulting
|
6,672
|
4,133
|
||||||
$
|
16,342
|
$
|
12,976
|
|||||
Operating income (loss):
|
||||||||
Performance Improvement Solutions
|
$
|
(738
|
)
|
$
|
(42
|
)
|
||
Nuclear Industry Training and Consulting
|
935
|
188
|
||||||
Change in fair value of contingent consideration, net
|
(254
|
)
|
69
|
|||||
Operating (loss) income
|
(57
|
)
|
215
|
|||||
Interest income, net
|
27
|
27
|
||||||
Loss on derivative instruments, net
|
(160
|
)
|
(118
|
)
|
||||
Other (expense) income, net
|
(3
|
)
|
102
|
|||||
(Loss) income before income taxes
|
$
|
(193
|
)
|
$
|
226
|
|||
16. |
Commitments and Contingencies
|
Item 2. |
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
● |
GSE Performance Solutions, Inc., a Delaware corporation;
|
● |
GSE Power Systems, AB, a Swedish corporation;
|
● |
GSE Engineering Systems (Beijing) Co. Ltd., a Chinese limited liability company;
|
● |
GSE Systems, Ltd., a Scottish limited liability company;
|
● |
EnVision Systems (India) Pvt. Ltd., an Indian limited liability company; and
|
● |
Hyperspring, LLC, an Alabama limited liability company.
|
● |
Universal Training Simulators:
These products complement the Self-Paced Training Tutorials by reinforcing what the student learned in the tutorial, putting it into practice on the Universal Simulator. The simulation models are high fidelity and engineering correct, but represent a typical plant or typical process, rather than the exact replication of a client's plant. We have delivered over 250 such simulation models to clients consisting of major oil companies and educational institutions.
|
● |
Part-Task Training Simulators:
Like the Universal Simulators, we provide other unique training solutions such as a generic nuclear plant simulator and VPanel® displays, which replicate control room hardware and simulator solutions specific to industry needs such as severe accident models to train on and aid in the understanding of events like the Fukushima Daiichi accident.
|
● |
Plant-Specific Operator Training Simulators:
These simulators provide an exact replication of the plant control room and plant operations. They provide the highest level of realism and training and allow users to practice their own plant-specific procedures. Clients can safely practice startup, shutdown, normal operations, as well as response to abnormal events we all hope they never have to experience in real life. Since our inception, we have delivered nearly 450 plant-specific simulators to clients in the nuclear power, fossil power and process industries worldwide.
|
($ in thousands)
|
Three months ended March 31,
|
|||||||||||||||
2017
|
%
|
2016
|
%
|
|||||||||||||
Revenue
|
$
|
16,342
|
100.0
|
%
|
$
|
12,976
|
100.0
|
%
|
||||||||
Cost of revenue
|
12,220
|
74.8
|
%
|
9,352
|
72.1
|
%
|
||||||||||
Gross profit
|
4,122
|
25.2
|
%
|
3,624
|
27.9
|
%
|
||||||||||
Operating expenses:
|
||||||||||||||||
Selling, general and administrative
|
3,592
|
22.0
|
%
|
2,757
|
21.2
|
%
|
||||||||||
Research and development
|
402
|
2.4
|
%
|
354
|
2.7
|
%
|
||||||||||
Restructuring charges
|
45
|
0.3
|
%
|
125
|
1.0
|
%
|
||||||||||
Depreciation
|
76
|
0.5
|
%
|
100
|
0.8
|
%
|
||||||||||
Amortization of definite-lived intangible assets
|
64
|
0.4
|
%
|
73
|
0.6
|
%
|
||||||||||
Total operating expenses
|
4,179
|
25.6
|
%
|
3,409
|
26.3
|
%
|
||||||||||
Operating (loss) income
|
(57
|
)
|
(0.4
|
)%
|
215
|
1.6
|
%
|
|||||||||
Interest income, net
|
27
|
0.2
|
%
|
27
|
0.2
|
%
|
||||||||||
Loss on derivative instruments, net
|
(160
|
)
|
(1.0
|
)%
|
(118
|
)
|
(0.9
|
)%
|
||||||||
Other (expense) income, net
|
(3
|
)
|
0.0
|
%
|
102
|
0.8
|
%
|
|||||||||
(Loss) income before income taxes
|
(193
|
)
|
(1.2
|
)%
|
226
|
1.7
|
%
|
|||||||||
Provision for income taxes
|
73
|
0.4
|
%
|
88
|
0.7
|
%
|
||||||||||
Net (loss) income
|
$
|
(266
|
)
|
(1.6
|
)%
|
$
|
138
|
1.1
|
%
|
($ in thousands)
|
Three months ended
|
|||||||
March 31,
|
||||||||
2017
|
2016
|
|||||||
Revenue:
|
||||||||
Performance Improvement Solutions
|
$
|
9,670
|
$
|
8,843
|
||||
Nuclear Industry Training and Consulting
|
6,672
|
4,133
|
||||||
Total revenue
|
$
|
16,342
|
$
|
12,976
|
($ in thousands)
|
Three months ended
|
|||||||||||||||
March 31,
|
||||||||||||||||
2017
|
%
|
2016
|
%
|
|||||||||||||
Gross profit:
|
||||||||||||||||
Performance Improvement Solutions
|
$
|
3,044
|
31.5
|
%
|
$
|
3,145
|
35.6
|
%
|
||||||||
Nuclear Industry Training and Consulting
|
1,078
|
16.2
|
%
|
479
|
11.6
|
%
|
||||||||||
Consolidated gross profit
|
$
|
4,122
|
25.2
|
%
|
$
|
3,624
|
27.9
|
%
|
($ in thousands)
|
Three months ended
|
|||||||||||||||
March 31,
|
||||||||||||||||
2017
|
%
|
2016
|
%
|
|||||||||||||
Selling, general and administrative expenses:
|
||||||||||||||||
Corporate charges
|
$
|
2,442
|
68.0
|
%
|
$
|
1,783
|
64.7
|
%
|
||||||||
Business development
|
685
|
19.0
|
%
|
786
|
28.5
|
%
|
||||||||||
Contingent consideration
|
254
|
7.1
|
%
|
(69
|
)
|
(2.5
|
%)
|
|||||||||
Other
|
211
|
5.9
|
%
|
257
|
9.3
|
%
|
||||||||||
Total
|
$
|
3,592
|
100.0
|
%
|
$
|
2,757
|
100.0
|
%
|
● |
A $4.9 million decrease in the Company's contract receivables, which is comprised of trade receivables and unbilled receivables. The Company's trade receivables, net of allowance for doubtful accounts, decreased approximately $7.4 million primarily due to the collection of $6.4 million in receivables during the first quarter of 2017 from a significant customer.
At March 31, 2017, trade receivables outstanding for more than 90 days, net of the bad debt reserve, totaled approximately $0.6 million as compared to $0.3 million at December 31, 2016.
The Company believes the entire 90-day balance at March 31, 2017, is collectible. The Company's unbilled receivables increased by approximately $2.4 million to $7.9 million at March 31, 2017, as compared to December 31, 2016. The increase in the unbilled receivables is due to the timing of contracted billing milestones of the Company's current projects, most of which relates to Hyperspring's largest customer. In April 2017, the Company invoiced $1.6
million
of the unbilled amounts; the remaining balance is expected to be invoiced and collected within one year.
|
● |
A $3.3 million decrease in billings in excess of revenue earned. The decrease is due to the timing of contracted billing milestones of the Company's current projects.
|
● |
A $1.2 million decrease in accounts payable, accrued compensation and accrued expenses. The decrease primarily reflects a decrease in Hyperspring accrued payroll due to the timing of their biweekly payroll cycle and the timing of payments made by the Company to vendors and subcontractors.
|
● |
A $0.3 million decrease in the Company's contract receivables. The Company's trade receivables, net of the allowance for doubtful accounts, decreased from $9.7 million at December 31, 2015 to $7.6 million at March 31, 2016. At March 31, 2016, trade receivables outstanding for more than 90 days, net of the bad debt reserve, totaled approximately $0.9 million as compared to $0.6 million at December 31, 2015.
The Company believes the entire 90-day balance at March 31, 2016, is collectible.
The Company's unbilled receivables increased by approximately $1.8 million to $5.2 million at March 31, 2016 as compared to December 31, 2015. The increase in the unbilled receivables is due to the
timing of contracted billing milestones of the Company's current projects. In April 2016, the Company invoiced $1.8 million of the unbilled amounts; the balance is expected to be invoiced and collected within one year.
|
● |
A $1.2 million increase in accounts payable, accrued compensation and accrued expenses. The increase reflects an increase in Hyperspring accrued payroll due to the timing of their biweekly payroll cycle and timing of payments made by the Company to vendors and subcontractors.
|
|
Three Months ended
|
|||||||
|
March 31,
|
|||||||
(in thousands)
|
2017
|
2016
|
||||||
Net (loss) income
|
$
|
(266
|
)
|
$
|
138
|
|||
Interest income, net
|
(27
|
)
|
(27
|
)
|
||||
Provision for income taxes
|
73
|
88
|
||||||
Depreciation and amortization
|
140
|
173
|
||||||
EBITDA
|
(80
|
)
|
372
|
|||||
Loss (gain) from the change in fair value of contingent consideration
|
254
|
(69
|
)
|
|||||
Restructuring charges
|
45
|
125
|
||||||
Stock-based compensation expense
|
596
|
247
|
||||||
Consulting support for finance restructuring
|
-
|
78
|
||||||
Adjusted EBITDA
|
$
|
815
|
$
|
753
|
|
Three Months ended
|
|||||||
|
March 31,
|
|||||||
|
2017
|
2016
|
||||||
|
||||||||
Net (loss) income
|
$
|
(266
|
)
|
$
|
138
|
|||
Loss (gain) from the change in fair value of contingent consideration
|
254
|
(69
|
)
|
|||||
Restructuring charges
|
45
|
125
|
||||||
Stock-based compensation expense
|
596
|
247
|
||||||
Consulting support for finance restructuring
|
-
|
78
|
||||||
Adjusted net income
|
$
|
629
|
$
|
519
|
||||
Diluted (loss) earnings per common share
|
$
|
(0.01
|
)
|
$
|
0.01
|
|||
Adjusted earnings per common share – Diluted
(a)
|
$
|
0.03
|
$
|
0.03
|
||||
Weighted average shares outstanding – Diluted
(a)
|
19,502,057
|
18,133,742
|
||||||
Item 3. |
Quantitative and Qualitative Disclosure about Market Risk
|
Item 4. |
Controls and Procedures
|
Item 1. |
Legal Proceedings
|
Item 1A. |
Risk Factors
|
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
Item 3. |
Defaults Upon Senior Securities
|
Item 4. |
Mine Safety Disclosures
|
Item 5. |
Other Information
|
Item 6. |
Exhibits
|
10.1
|
Employment Agreement between Bahram Meyssami and GSE Systems, Inc. dated as of December 1, 2015, filed herewith.
|
|
10.2
|
Restricted Share Unit Agreement between Bahram Meyssami and GSE Systems, Inc. dated as of December 1, 2015, filed herewith.
|
|
10.3
|
Amendment to Restricted Share Unit Agreement between Bahram Meyssami and GSE Systems, Inc. dated as of July 1, 2016, filed herewith.
|
|
31.1
|
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes- Oxley Act of 2002, filed herewith.
|
|
31.2
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
|
|
32.1
|
Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.
|
|
101.INS*
|
XBRL Instance Document
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase
|
a.
|
Base Salary
. The Company shall pay to Executive an annual base salary (the "
Base Salary
") of Two Hundred Twenty Five Thousand Dollars ($225,000). The Executive's Base Salary shall be reviewed at least annually with the Board, and the Board may, but shall not be required to, increase (but not decrease) the Base Salary during the Term based upon changes in cost of living, the Executive's performance and other factors deemed relevant by the Board. The Base Salary will be payable at such intervals as salaries are paid generally to other executive officers of the Company.
|
b.
|
Bonus
. For each fiscal year of the Term, beginning with fiscal year 2016, the Executive shall be eligible to earn an annual bonus award (the "
Bonus
") of up to 25% of Base Salary, based upon the achievement of annual performance goals established by Board prior to the beginning of each fiscal year. The amount of Bonus to be paid to Executive for any year of this Agreement may, at the sole discretion of the Board of Directors of the Company, be prorated for the number of months which Executive was employed by the Company during such year. Any Bonus shall be paid on or prior to March 15 of the following year.
|
c.
|
Restricted Stock Units
.
|
i.
|
Upon execution of this Agreement, the Executive will be granted 200,000 performance-restricted stock units ("
RSUs
"), subject to vesting and all other terms and conditions set forth in the Company's 1995 Long Term Incentive Plan and in a written grant agreement issued to Executive in connection with the grant of such RSUs.
|
ii.
|
For each fiscal year during the Initial Term, commencing with fiscal year 2016, the Executive will have the potential to earn 25% of his Base Salary in RSUs, non-qualified stock options or a combination thereof, based upon metrics, such as performance against budget, profitability and stock price performance, as determined by the Board of Directors prior to the beginning of each fiscal year. All such grants shall be made via a written grant agreement.
|
d.
|
Benefits
. Executive shall be entitled to participate in all employee benefit plans maintained by the Company for its senior executives or employees including, without limitation, the Company's medical, dental, vision, 401(k) and life insurance plans and the following benefits:
|
i.
|
Vacation
. Executive shall be entitled to vacation in accordance with the Company's policy for its senior executives.
|
ii.
|
Automobile
. The Company shall pay the gasoline in connection with Executive's automobile in accordance with the written policy and guidelines established by the Company for executive officers.
|
iii.
|
Medical and Dental/Vision Insurance
. The Company shall pay Executive's monthly Medical and Dental/Vision Insurance premiums in association with Company provided health insurance plans.
|
a.
|
Acknowledgement
s. The Executive acknowledges and agrees that the services to be rendered by the Executive to the Company are of a special and unique character; that the Executive will obtain knowledge and skill relevant to the Company's industry, methods of doing business and marketing and investment strategies by virtue of the Executive's employment; and that the restrictive covenants and other terms and conditions of this Agreement are reasonable and reasonably necessary to protect the legitimate business interest of the Company. The Executive further acknowledges that: the amount of the Executive's compensation reflects, in part, the Executive's obligations and the Company's rights under this Agreement; that the Executive has no expectation of any additional compensation, royalties or other payment of any kind not otherwise referenced herein in connection herewith; and that the Executive will not be subject to undue hardship by reason of his full compliance with the terms and conditions of this Agreement or the Company's enforcement thereof.
|
b.
|
Non-Competition.
Because of the Company's legitimate business interest as described herein and the good and valuable consideration offered to the Executive, during the Term and for the 12-month period beginning on the last day of the Executive's employment with the Company, the Executive agrees and covenants not to engage in Prohibited Activity within the United States. For purposes of this Section 6, "
Prohibited Activity
" means any activity to which the Executive contributes his knowledge, directly or indirectly, in whole or in part, as an employee, employer, owner, operator, manager, advisor, consultant, agent, employee, partner, director, stockholder, officer, volunteer, intern or any other similar capacity to an entity engaged in the same or similar business as the Company anywhere in the world. Nothing herein shall prohibit the Executive from purchasing or owning less than five percent (5%) of the publicly traded securities of any corporation, provided that such ownership represents a passive investment and that the Executive is not a controlling person of, or a member of a group that controls, such corporation.
|
c.
|
Non-solicitation of Employees
. The Executive agrees and covenants not to directly or indirectly solicit, hire, recruit, attempt to hire or recruit, or induce the termination of employment of any employee of the Company during the Term and the 12-month period beginning on the last day of the Executive's employment with the Company.
|
d.
|
Non-solicitation of Customers
. The Executive understands and acknowledges that because of the Executive's experience with and relationship to the Company, he will have access to and learn about much or all of the Company's customer information. "
Customer Information
" includes, but is not limited to, names, phone numbers, addresses, e-mail addresses, order history, order preferences, chain of command, pricing information and other information identifying facts and circumstances specific to the customer. The Executive understands and acknowledges that loss of this customer relationship and/or goodwill will cause significant and irreparable harm to the Company. The Executive agrees and covenants, during the Term and for the 12-month period following the effective date of termination of this Agreement for any reason, not to directly or indirectly solicit, contact (including but not limited to e-mail, regular mail, express mail, telephone, fax, and instant message), attempt to contact or meet with the Company's current customers for purposes of offering or accepting goods or services similar to or competitive with those offered by the Company or for purposes of inducing any such customer to terminate its relationship with the Company.
|
e.
|
Confidential Information
. All Confidential Information which Executive may now possess, may obtain during the Term, or may create prior to the end of the Term relating to the business of the Company or of any of its customers or suppliers shall not be published, disclosed, or made accessible by him to any other person, firm, or corporation either during or after the termination of his employment or used by him except during the Term in the business and for the benefit of the Company, in each case without prior written permission of the Company. Executive shall return all tangible evidence of any Confidential Information to the Company prior to or at the termination of his employment. For purposes of this Agreement, "
Confidential Information
" means any and all information related to the Company or any of its subsidiaries that is not generally known by others with whom they compete or do business.
|
f.
|
Enforcement
. Executive acknowledges and agrees that the covenants contained herein are fair and reasonable in light of the consideration paid hereunder, and that damages alone shall not be an adequate remedy for any breach by Executive of his covenants which then apply and accordingly expressly agrees that, in addition to any other remedies which the Company may have, the Company shall be entitled to injunctive relief in any court of competent jurisdiction for any breach or threatened breach of any such covenants by Executive. Nothing contained herein shall prevent or delay the Company from seeking, in any court of competent jurisdiction, specific performance or other equitable remedies in the event of any breach or intended breach by Executive of any of his obligations hereunder.
|
g.
|
Tolling
. The period of time applicable to any covenant in this Section 6 will be extended by the duration of any violation by Executive of such covenant.
|
h.
|
Reformation
. If any covenant in this Section 6 is held to be unreasonable, arbitrary, or against public policy, such covenant will be considered to be divisible with respect to scope, time, and geographic area, and such lesser scope, time, or geographic area, or all of them, as a court of competent jurisdiction may determine to be reasonable, not arbitrary, and not against public policy, will be effective, binding, and enforceable against Executive.
|
a.
|
Death
. Executive's employment hereunder shall terminate upon his death.
|
b.
|
Disability
. If, as a result of Executive's incapacity due to physical or mental illness, Executive shall have been unable to perform his duties hereunder on a full-time basis for a period of three (3) consecutive months, or for 180 days in any 12 month period (a "
Disability
"), the Company may, on 30 days written Notice of Termination (defined in Section 8(e)), terminate Executive's employment if Executive fails to return to the performance of his duties hereunder on a full-time basis within said period.
|
c.
|
Cause
. The Company may terminate Executive's employment hereunder for Cause. For purposes of this Agreement, the Company shall have "
Cause
" to terminate Executive's employment upon the occurrence of any of the following:
|
i.
|
the willful and continued failure by Executive to substantially perform his material duties or obligations hereunder (other than any such failure resulting from Executive's incapacity due to physical or mental illness), after written demand for substantial performance is delivered by the Company that specifically identifies the manner in which the Company believes Executive has not substantially performed his duties or obligations, and provides the Executive with at least 30 days to effect a cure;
|
ii.
|
the willful engaging by Executive in misconduct which, in the reasonable opinion of the Board, will have a material adverse effect on the reputation, operations, prospects or business relations of the Company;
|
iii.
|
the conviction of Executive of any felony or the entry by Executive of any plea of nolo contendere in response to an indictment for a crime involving moral turpitude;
|
iv.
|
Executive abuses alcohol, illegal drugs or other controlled substances which impact Executive's performance of his duties;
|
v.
|
the material breach by Executive of a material term or condition of this Agreement.
|
d.
|
Termination Without Cause
. The Executive's employment hereunder may be terminated without cause by either the Company or the Executive at any time upon at least 30 days' prior written notice. The giving by the Company of notice of its intent not to extend the Term pursuant to Section 3 shall be deemed, at the option of the Executive, to be a termination of his employment without cause ("
Deemed Termination
"). Executive may exercise that option by giving written notice thereof to the Company within 30 days of his receipt of the notice of non-renewal.
|
e.
|
Notice of Termination
. Any termination of Executive's employment (other than termination pursuant to Section 8(a)) shall be communicated by a Notice of Termination given by the terminating party to the other party hereto. For purposes of this Agreement, a "
Notice of Termination
" shall mean a written notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive's employment under the provision so indicated.
|
f.
|
Date of Termination
. "
Date of Termination
" shall mean (i) if Executive's employment is terminated by his death, the date of his death, (ii) if Executive's employment is terminated pursuant to Section 8(b), 30 days after Notice of Termination is given (provided that Executive shall not have returned to the performance of his duties on a full-time basis during such 30-day period), (iii) if a Deemed Termination occurs, upon the date of Executive's notice to the Company of exercise of his option to treat such event as a termination without Cause, and (iv) if Executive's employment is terminated for any other reason, the date specified in the Notice of Termination, which shall not be earlier than the date on which the Notice of Termination is given.
|
a.
|
Disability
. During any period that Executive fails to perform his duties hereunder as a result of incapacity due to physical or mental illness ("
disability period
"), Executive shall continue to receive his full salary at the rate then in effect for such period until his employment is terminated pursuant to Section 8(b), provided that payments so made to Executive during the disability period shall be reduced by the sum of the amounts, if any, payable to Executive at or prior to the time of any such payment under disability benefit plans of the Company and which were not previously applied to reduce any such payment, and the Company shall have no further obligation to the Executive.
|
b.
|
For Cause
. If Executive's employment is terminated for Cause, the Company shall pay Executive his full salary through the Date of Termination at the rate in effect at the time Notice of Termination is given, and the Company shall have no further obligation to the Executive.
|
c.
|
Any other Reason
. If Executive's employment shall be terminated by the Company for a reason other than Death, Disability or Cause, or if Executive terminates his employment for Good Reason (defined below), upon Executive's execution of a release of claims in favor of the Company, its affiliates and their respective officers and directors in a form provided by the Company (the "
Release
") and such Release becoming effective within 21 days following the Termination Date:
|
i.
|
the Company will continue to pay the Executive his Base Salary for a period of six months, payable at such intervals as salaries are paid generally to other executive officers of the Company;
|
ii.
|
the Executive shall continue to be eligible to participate in all medical, dental, vision and 401(k) plan benefits, including company match (collectively, "
Benefits
"), on the same terms and at the same level of participation and company contribution to the cost thereof, as in effect at the time of termination of employment for a period of six months following termination to the extent Executive remains eligible under the applicable employee benefit plans and to the extent Executive's eligibility is not contrary to, or does not negate, the tax favored status of the plans or of the benefits payable under the plan. If Executive is unable to continue to participate in any employee benefit plan or program provided for under this Agreement, Executive shall be compensated in respect of such inability to participate through payment by GSE to Executive, in advance, of an amount equal to the annual cost that would have been incurred by GSE if the Executive were able to participate in such plan or program.
|
iii.
|
Executive shall receive a prorated Bonus equal to the product of (I) the Bonus, if any, that the Executive would have earned for the calendar year in which the Date of Termination occurred had he been employed as of the last day of such year, based on the Company's actual results of operations for such year and (II) a fraction, the numerator of which is the number of days the Executive was employed by the Company during the year of termination and the denominator of which is the number of days in such year. The prorated Bonus shall be paid on the date that annual bonuses are paid to similarly situated employees, but in no event later than the date which not later than two and one-half (2 ½) months following the end of the calendar year in which the Date of Termination occurs.
|
d.
|
"
Good Reason
" shall mean the occurrence of any of the following: (a) Executive's duties, responsibilities or authority are materially reduced as compared to those of Executive's current position without his consent; (b) Executive's Base Salary (as the same may be increased at any time hereafter) or Bonus are reduced; (c) Executive's Benefits are either discontinued or materially reduced, in the aggregate; (d) Executive's primary office or location is moved more than fifty (50) miles from Executive's current office or location; or (e) either the Company or any successor company materially breaches this Agreement.
|
a.
|
If Executive terminates his employment for Good Reason within one year following the effective date of a Change of Control, Executive shall, in lieu of any benefits provided for in Section 9, continue to receive the Base Salary and Benefits that Executive is receiving as of the effective date of the Change of Control for a period of six (6) months from the date of termination of his employment. Such Base Salary and Benefits shall be paid at such intervals as salaries are paid generally to other executive officers of the Company.
|
b.
|
In addition, the Executive shall also be entitled to receive, on the Date of Termination, an amount, payable in one lump sum, equal to 50% of the average of the Bonus amounts paid to Executive for the two years prior to the year in which the Change of Control takes place.
|
c.
|
In the event of Executive's decision to terminate employment for Good Reason, Executive must give notice to Company of the existence of the conditions giving rising to the termination for Good Reason within ninety (90) days of the initial existence of the conditions. Upon such notice, Company shall have a period of thirty (30) days during which it may remedy the conditions ("
Cure Period
"). If the Company fails to cure the conditions constituting the Good Reason during the Cure Period to Executive's reasonable satisfaction, Executive's termination of employment must occur within a period of ninety (90) days following the expiration of the Cure Period in order for the termination to constitute a termination pursuant to Good Reason for purposes of this Agreement.
|
d.
|
For purposes of this Agreement, a "
Change in Control
" of the Company shall be deemed to have occurred as of the first day that any one or more of the following conditions shall have been satisfied:
|
i.
|
Any Person (other than a Person in control of the Company as of the date of this Agreement, or other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company, or a company owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of voting securities of the Company) becomes the beneficial owner, directly or indirectly, of securities of the Company representing a majority of the combined voting power of the Company's then outstanding securities; or
|
ii.
|
The stockholders of the Company approve: (x) a plan of complete liquidation of the Company (which includes a termination and liquidation of all Executive's rights under any arrangement governed by Section 409A of the Internal Revenue Code of 1986, as amended ("
Code
"); or (y) an agreement for the sale or disposition of all or substantially all the Company's assets; or (z) a merger, consolidation, or reorganization of the Company with or involving any other corporation, other than a merger, consolidation, or reorganization that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least a majority of the combined voting power of the voting securities of the Company (or such surviving entity) outstanding immediately after such merger, consolidation, or reorganization.
|
iii.
|
For purposes of this definition of Change in Control, "
Person
" shall have the meaning ascribed to such term in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the "
1934 Act
"), and used in Section 13(d) and 14(d) thereof, including a "group" as defined in Section 13(d) thereof, and "
Beneficial Owner
" shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and regulations under the 1934 Act.
|
·
|
Oversee and actively manage the staff of the entire Technology organization.
|
·
|
Work with key stakeholders within (sales, Executive Team) and beyond the Company (customers) to understand the requirements for delivering Technology and Products to advance the Company goals in driving revenue and profitability growth.
|
·
|
Be responsible for the technical means and methods of developing and delivering Technology and Products to the marketplace.
|
·
|
Identify opportunities and risks for the business.
|
·
|
Monitor technology and trends that could impact the Company.
|
·
|
Participate in management decisions about corporate strategy, execution and governance.
|
·
|
Communicate the Company's technology strategy to partners, management, investors and employees.
|
·
|
Maintain current information about technology standards and compliance regulations.
|
GSE SYSTEMS, INC.
|
|
By:
Name: Kyle J. Loudermilk Title: President and Chief Executive Officer |
|
_____________________
Bahram Meyssami |
GSE SYSTEMS, INC.
By: _____________________________________
Daniel Pugh
Senior Vice President, General Counsel
and Risk Management Officer
|
EXECUTIVE
_____________________________________
Bahram Meyssami |
1.
|
I have reviewed this quarterly report on Form 10-Q of GSE Systems, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant, as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors:
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting;
|
Date: May 15, 2017
|
/s/ Kyle J. Loudermilk
|
|
Kyle J. Loudermilk
|
||
Chief Executive Officer
(Principal Executive Officer)
|
1.
|
I have reviewed this quarterly report on Form 10-Q of GSE Systems, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant, as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors:
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting;
|
Date: May 15, 2017
|
/s/ Emmett A. Pepe
|
|
Emmett A. Pepe
|
||
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: May 15, 2017
|
/s/ Kyle J. Loudermilk
|
/s/ Emmett A. Pepe
|
||
Kyle J. Loudermilk
|
Emmett A. Pepe
|
|||
Chief Executive Officer
|
Chief Financial Officer
|
|||